A lipid excipient
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Product Categories

Research Area

ALC-0159

Item No. 34336

Technical Information
Formal Name
α-[2-(ditetradecylamino)-2-oxoethyl]-ω-methoxy-poly(oxy-1,2-ethanediyl)
CAS Number
1849616-42-7
Synonyms
  • N,N-ditetradecylacetamide PEG(2000)
  • N,N-ditetradecylacetamide Polyethylene Glycol-2000
Molecular Formula
(C2H4O)nC31H63NO2
Purity
≥95%
MW
Average: 2400 Da
A solid
DMF: 10 mg/mlDMF:PBS (pH 7.2) (1:2): 0.3 mg/mlDMSO: Slightly SolubleEthanol: 1 mg/ml
SMILES
COCCOCC(N(CCCCCCCCCCCCCC)CCCCCCCCCCCCCC)=O
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Lipid Nanoparticle Resource Center for Additional Tools & Resources
    EXPLORE NOW
    Product Description

    ALC-0159 is a lipid excipient.1 Formulations containing ALC-0159 have been used in the development of lipid nanoparticles (LNPs) for the delivery of mRNA-based vaccines.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Cortés, H., Hernández-Parra, H., Bernal-Chávez, S.A., et alNon-ionic surfactants for stabilization of polymeric nanoparticles for biomedical uses. Materials (Basel) 14(12), 3197 (2021).

    Product Citations

    Han, E.L., Kim, D., Murray, A.M., et alHigh-throughput in vivo screening identifies structural factors driving mRNA lipid nanoparticle delivery to the brain. ACS Nano 20(4), 3807-3820 (2026).

    Mata, E., Broset, E., Matute, C., et alPreserved efficacy of lyophilized SARS-CoV-2 mRNA vaccine incorporating novel ionizable lipids after one year at 25 °C. NPJ Vaccines 10(1), 135 (2025).

    Wojcechowskyj, J.A., Jong, R.M., Mäger, I., et alControlling reactogenicity while preserving immunogenicity from a self-amplifying RNA vaccine by modulating nucleocytoplasmic transport. NPJ Vaccines 10(1), 85 (2025).